Heron Therapeutics Stock Forecast

Sell candidate since Aug 10, 2026

The Heron Therapeutics stock price fell by -31.74% on the last day (Monday, 10th Aug 2026) from $0.491 to $0.335. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 28.62% from a day low at $0.325 to a day high of $0.418. The price has been going up and down for this period, and there has been a -27.05% loss for the last 2 weeks. Volume has increased on the last day by 9 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 11 million shares were bought and sold for approximately $3.79 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -47.40% during the next 3 months and, with a 90% probability hold a price between $0.0642 and $0.254 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

HRTX Signals & Forecast

There are few to no technical positive signals at the moment. The Heron Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.478 and $0.453. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, August 04, 2026, and so far it has fallen -34.51%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Heron Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0929 between high and low, or 28.62%. For the last week, the stock has had daily average volatility of 11.45%.

Heron Therapeutics is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HRTX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Heron Therapeutics to open at $0.359, and during the day (based on 14 day Average True Range), to move between $0.314 and $0.356, which gives a possible trading interval of +/-$0.0429 (+/-13.69%) up or down from last closing price. If Heron Therapeutics takes out the full calculated possible swing range there will be an estimated 13.69% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.406, some $0.0709 (21.16%) from the current price of $0.335, our system finds the risk reward not very attractive.

Is Heron Therapeutics stock A Buy?

Heron Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.522 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.359 ( 7.17%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk